Squamous Cell Carcinoma of Head and Neck: 2221 Clinical Trials, Page 1 of 223

1 2 3 4 5 …10 15 20 … »Last Page »

Hide Studies Not Open or Pending

A Study to Evaluate the Efficacy and Safety of MRG003 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck

Condition(s):Recurrent or Metastatic Squamous Cell Carcinoma of Head and NeckLast Updated:April 30, 2021Recruiting

Changes in Body Composition After EPA Supplementation in Head and Neck Patients

Condition(s):Squamous Cell Carcinoma of Head and NeckLast Updated:September 4, 2019Completed

Pemetrexed as Salvage Treatment in Squamous Cell Carcinoma of Head and Neck

Condition(s):Squamous Cell Carcinoma of Head and NeckLast Updated:March 5, 2013Unknown status

Valproic Acid Plus Cisplatin and Cetuximab in Recurrent and/or Metastatic Squamous Cell Carcinoma of Head and Neck

Condition(s):Squamous Cell Carcinoma of the Head and NeckLast Updated:October 13, 2021Active, not recruiting

Study to Evaluate the Response Rate to Therapy With Docetaxel and Cisplatin in Unresectable Locally Advanced Squamous Cell Carcinoma of Head and Neck

Condition(s):Squamous Cell Carcinoma of Head and NeckLast Updated:October 8, 2015Completed

Randomised Phase II, Cetuximab in Combination With 5FU and Cisplatin or Carboplatin Versus Cetuximab in Combination With Paclitaxel and Carboplatin for Treatment of Patients With Metastatic Squamous Cell Carcinoma of the Head and Neck

Condition(s):Squamous Cell Carcinoma of the Head and NeckLast Updated:May 21, 2013Unknown status

A Study of Atezolizumab Plus Tiragolumab and Atezolizumab Plus Placebo as First-Line Treatment in Participants With Recurrent/Metastatic PD-L1 Positive Squamous Cell Carcinoma of the Head and Neck

Condition(s):Squamous Cell Carcinoma of Head and NeckLast Updated:March 9, 2023Active, not recruiting

A Phase I Study of LJM716 in Squamous Cell Carcinoma of Head and Neck, or HER2+ Breast Cancer or Gastric Cancer

Condition(s):HER2 + Breast Cancer, HER2 + Gastric Cancer, Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma; HER2 + Breast Cancer; HER2 + Gastric Cancer; Squamous Cell Carcinoma of Head and Neck; Esophageal Squamous Cell CarcinomaLast Updated:December 19, 2020Completed

NT-I7 for the Treatment of Recurrent Squamous Cell Carcinoma of Head and Neck Undergoing Surgery

Condition(s):Recurrent Head and Neck Squamous Cell Carcinoma; Recurrent Hypopharyngeal Squamous Cell Carcinoma; Recurrent Laryngeal Squamous Cell Carcinoma; Recurrent Oral Cavity Squamous Cell Carcinoma; Recurrent Oropharyngeal Squamous Cell Carcinoma; Resectable Oropharyngeal Squamous Cell CarcinomaLast Updated:July 11, 2022Recruiting

Postoperative Concurrent Chemoradiotherapy With Docetaxel for High-Risk Squamous Cell Carcinoma of Head and Neck

Condition(s):Head-and-neck Cancer; Squamous Cell CarcinomaLast Updated:August 19, 2020Completed

1 2 3 4 5 …10 15 20 … »Last Page »

Trial Bulletin .com

Clinical Trials by Category

Clinical Trials Alphabetically

About

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.